First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience

Aly Khan A. Lalani, Haocheng Li, Daniel Y.C. Heng, Lori Wood, Austin Kalirai, Georg A. Bjarnason, Hao Wen Sim, Christian K. Kollmannsberger, Anil Kapoor, Sebastien J. Hotte, Marie Vanhuyse, Piotr Czaykowski, M. Neil Reaume, Denis Soulieres, Peter Venner, Scott North, Naveen S. Basappa